← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cytograft Tissue Engineering, Inc.
Novato, CA
$5,549,992
Total funding
6
Grants
Funding over time
peak $901.8K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$5,549,992 · 6
By mechanism
R44$4,813,096 · 2
R43$736,896 · 4
Investigators at Cytograft Tissue Engineering, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Commercialization of a Tissue Engineered Blood Vessel$901,757
R44 · FY2006 · HL
Commercialization of a Tissue Engineered Blood Vessel$851,862
R44 · FY2005 · HL
Cell-synthesized Thread-based Tissue Engineering$768,475
R44 · FY2011 · HL
Commercialization of a Tissue Engineered Blood Vessel$728,532
R44 · FY2007 · HL
Cell-synthesized Thread-based Tissue Engineering$705,170
R44 · FY2012 · HL
in vivo Evaluation of a Tissue Blood Vessel$429,750
R44 · FY2003 · HL
in vivo Evaluation of a Tissue Blood Vessel$427,550
R44 · FY2004 · HL
Cell-synthesized Thread-based Tissue Engineering$215,415
R43 · FY2010 · HL
Development of a Biological Stent Graft for Aorta Aneurysm Repair$214,912
R43 · FY2010 · HL
Development of a TAVI Device with a Reduced Crossing Profile$207,689
R43 · FY2013 · HL
AUTOMATED PROCESS FOR A TISSUE ENGINEERED BLOOD VESSEL$98,880
R43 · FY2000 · HL